Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
BioStock: PHI’s CEO comments on the approved US listing
PHI has been approved for a dual US listing in addition to its primary listing on the Swedish Spotlight market. What does this mean for the company’s shareholders, and how might it impact the company’s long-term valuation? BioStock reached out to PHI’s CEO Patrik Eschricht to discuss this and the upcoming redemption of the TO4 warrants that could potentially raise SEK 20.8 million in October.
OTC Market Center in New York welcomes PHI
Our very own ‘big apple’ news — PHI’s shares (OTCQB:PHIXF) are now also trading on the US-OTCQB Market! Go and see some snapshots and our CEO Patrik speaking on this exciting new chapter.
PHI enters the US capital market – shares now also traded on OTCQB
PHI is thrilled to announce its official approval for also listing on the OTCQB Venture Market in the U.S., with trading commencing Thursday, August 15th. (OTCQB:PHIXF).
New date: Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 September 2024
Phase Holographic Imaging PHI AB (publ), reg. no. 556542-7811 (the “Company”), will hold an extraordinary general meeting on 2 September at 14.00 at the Company’s premises at Skiffervägen 48 in Lund.
PHI postpones the extraordinary general meeting until September 2, 2024
The Board of Directors of PHI AB has decided to postpone the date of the extraordinary general meeting until September 2, 2024. An updated notice for the extraordinary general meeting will be issued shortly.